Sign in
VVOS Stock Price, Chart, Stats & News
Vivos Therapeutics, Inc.
Save
2.75M
Market cap
–
Current P/E
–
Forward P/E
VVOS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 55.74% |
Operating margin | -91.02% |
Pretax margin | -98.77% |
Net margin | -98.77% |
Effective tax rate | – |
ROA | -66.70% |
ROE | -351.28% |
D/E | 4.94x |
Interest coverage ratio | – |
VVOS valuation
P/E | – |
P/S | 0.39x |
P/B | 4.98x |
P/CF | -0.88x |
P/FCF | -0.47x |
P/OCF | -0.88x |
PEG | 0.15x |
EV multiple | 0.17x |
About
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children.
Similar securities
Based on sector and market capitalization
Report issue